Rezvan Parvizi

MedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and PharmaceuticsEnergy

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Mycophenolate mofetil directly modulates myeloid viability and pro-fibrotic activation of human macrophages”.

Mycophenolate mofetil directly modulates myeloid viability and pro-fibrotic activation of human macrophages

Lara D. Veeken(2024)10.1093/rheumatology/keae517

N/A

0.358DataRank · unranked

6 citations

Rezvan Parvizi, Nicole M. Orzechowski, Michael L. Whitfield, Patricia A. Pioli, Emily A. Morris

Single-cell epigenomic dysregulation of Systemic Sclerosis fibroblasts via CREB1/EGR1 axis in self-assembled human skin equivalents

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.22.586316

N/A

0DataRank · unranked

3 citations

Noelle N. Kosarek, Rezvan Parvizi, Helen Jarnagin, Gretel M. Torres, Rajan Bhandari +11 more

RUNX1 is expressed in a subpopulation of dermal fibroblasts and is associated with disease severity of systemic sclerosis

Annals of the Rheumatic Diseases(2025)10.1016/j.ard.2025.10.033

N/A

0DataRank · unranked

0 citations

Zhiyun Gong, Helen Jarnagin, Diana M. Toledo, Tamar R. Abel, Dillon Popovich +17 more